Health Care Professional View

  1. Home
  2. Products
  3. BIOCRYL RAPIDE™ Biocomposite Material

BIOCRYL RAPIDE™ Biocomposite Material

BIOCRYL RAPIDE™ is a biocomposite material. A proprietary Micro-Particle Dispersion (MPD) manufacturing process ensures a homogenous dispersion of the composite materials*, while ensuring osteoconductive β-TCP is in close apposition with the surrounding bone tissues.

Contact Us
Instructions for Use
BIOCRYL RAPIDE™ Biocomposite Material

Features & Benefits

  • One Material, Multiple Implant Options

    DePuy Synthes Mitek Sports Medicine offers a BIOCRYL RAPIDE™ Family of Implants consisting of suture anchors and interference screws.

  • BioComposite 70% PLGA/30% β-TCP

    Faster resorbing Second-Generation Resorbable Co-Polymer of Poly-L-Lactic Acid and Poly-Glycolic Acid (PLGA) plus β-TriCalcium Phosphate (β-TCP).1

  • Resorbable & Promotes Boney Ingrowth

    Pre-clinical and clinical testing has shown that BIOCYL RAPIDE Material resorbs over time, followed by bone in-growth.1,2,

  • Pure Medical Grade β-TCP

    Ensures purity of β-TCP without added fillers.

  • Micro Particle Dispersion Technology

    MPD is a proprietary manufacturing process that ensures a homogenous blend of β-TCP and PLGA particles. Dispersion of the composite particles is critical to the material strength properties.3

  • Radiopaque

    β-TCP enables the implant to be visible on x-ray.

References

* Non-homogeneous composites may result in a material with compromised or variable strength properties due to stress risers within the material.

1.    Poandl T., et. al. “A New Faster-Absorbing Biocomposite Material: Long-Term In-Vivo Tissue Reaction and Absorption.” Poster presentation, Spring AANA, (May) 2005.
2.    Barber FA, Dockery WD, Hrnack, SA, Long-Term Degradation of a Poly-Lactide Co-Glycolide/β-Tricalcium Phosphate Biocomposite Interference screw. Arthroscopy, Vol 27, No. 5, pp.637-643.
3.    Long-Term In-Vivo Tissue Reaction and Absorption, Center for Biomaterials & Advanced Technologies, Medical Devices Group, a division of ETHICON, INC.

Indication Statement

For product details such as indication, contraindication, warning and precaution please consult the IFU.

109199-190311

© DePuy Synthes Companies 2019. All Rights Reserved.
This site is published by the DePuy Synthes Companies, which are solely responsible for its content.
This site is for visitors from Europe, Middle East and Africa.
The third party trademarks used herein are trademarks of their respective owners